Journal provides insight into the way a workstation is transforming laboratory automation applications in drug discovery, genomics, proteomics and clinical diagnostics
Just published, issue 3 of the Tecan Journal provides a customer-focused global insight into the way that the Freedom Evo laboratory workstation is transforming laboratory automation applications in drug discovery, genomics, proteomics and clinical diagnostics.
As with previous issues, new tools for automated research are presented in the form of customer articles. Pioneering research into clinical proteomics by Toshihide Nishimura and Takao Kawakami from Medical ProteoScope is described.
Using a Tecan Genesis workstation to automate the process of protein extraction, denaturisation and digestion, the researchers are establishing systematic protein analysis at various sites in collaboration with Tokyo Medical University.
A further report details the work of the group of Cesare Gessler at the Institute of Plant Sciences of the Swiss Federal Institute of Technology (Zurich) into investigating the mechanisms and to find better solutions to control downy mildew, a common grape disease. A high-throughput plant DNA isolation technology is described that is playing a pivotal role in plant genotyping projects, such as population studies and plant breeding, GMO investigations.
In line with the requirements of the EU In Vitro Diagnostic Directive 98/79/EC (IVD-D) to further improve the safety, quality and efficacy of diagnostic medical devices, Tecan introduces in issue 3 its new IVD-D compliant product portfolio for clinical diagnostics.
